a public good project by the
Synthesis
Company
of California

© 2026

Raymond D. Blind | doi.page

0 works0 citations0 h-index

Raymond D. Blind

Vanderbilt University(US)Vanderbilt University Medical Center(US)

Publications by Year

Research Areas

Estrogen and related hormone effects, Protein Kinase Regulation and GTPase Signaling, PI3K/AKT/mTOR signaling in cancer, Drug Transport and Resistance Mechanisms, RNA Research and Splicing

Most-Cited Works

→ Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression(2008)274 cited
→ Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation(2009)151 cited
→ Direct Modification and Activation of a Nuclear Receptor–PIP ₂ Complex by the Inositol Lipid Kinase IPMK(2012)121 cited
→ Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes(2008)119 cited
→ The signaling phospholipid PIP ₃ creates a new interaction surface on the nuclear receptor SF-1(2014)98 cited
→ Structure of SF-1 Bound by Different Phospholipids: Evidence for Regulatory Ligands(2008)85 cited

→ Small Molecule Agonists of the Orphan Nuclear Receptors Steroidogenic Factor-1 (SF-1, NR5A1) and Liver Receptor Homologue-1 (LRH-1, NR5A2)(2011)

78 cited

→ Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks(2018)75 cited

→ Regulation of C. elegans Fat Uptake and Storage by Acyl-CoA Synthase-3 Is Dependent on NR5A Family Nuclear Hormone Receptor nhr-25(2010)64 cited

→ Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket(2015)59 cited